...
首页> 外文期刊>Journal of Medicinal Chemistry >Chromodomain Antagonists That Target the Polycomb-Group Methyllysine Reader Protein Chromobox Homolog 7 (CBX7)
【24h】

Chromodomain Antagonists That Target the Polycomb-Group Methyllysine Reader Protein Chromobox Homolog 7 (CBX7)

机译:针对多梳基甲基赖氨酸阅读器蛋白Chromobox Homolog 7(CBX7)的色域拮抗剂

获取原文
获取原文并翻译 | 示例
           

摘要

We report here a peptide-driven approach to create first inhibitors of the chromobox homolog 7 (CBX7), a methyllysine reader protein. CBX7 uses its chromodomain to bind histone 3, lysine 27 trimethylated (H3K27me3), and this recognition event is implicated in silencing multiple tumor suppressors. Small trimethyllysine containing peptides were used as the basic scaffold from which potent ligands for disruption of CBX7-H3K27me3 complex were developed. Potency of ligands was determined by fluorescence polarization and/or isothermal titration calorimetry. Binding of one ligand was characterized in detail using 2D NMR and X-ray crystallography, revealing a structural motif unique among human CBX proteins. Inhibitors with a ~200 nM potency for CBX7 binding and 10-fold/400-fold selectivity over related CBX8/CBX1 proteins were identified. These are the first reported inhibitors of any chromodomain.
机译:我们在这里报告了一种肽驱动的方法来创建第一个抑制剂的染色体盒同系物7(CBX7),一种甲基赖氨酸阅读器蛋白。 CBX7使用其色域结合组蛋白3,赖氨酸27三甲基化(H3K27me3),此识别事件与沉默多个肿瘤抑制因子有关。使用小的含三甲基赖氨酸的肽作为基础支架,从中开发了可破坏CBX7-H3K27me3复合物的有效配体。通过荧光偏振和/或等温滴定量热法测定配体的效力。使用2D NMR和X射线晶体学详细描述了一个配体的结合,揭示了人类CBX蛋白独特的结构基序。鉴定出与相关CBX8 / CBX1蛋白相比,具有约200 nM的CBX7结合力和10倍/ 400倍选择性的抑制剂。这些是第一个报道的任何色域抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号